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SUMMARY 
Objective: The Jirapa District in Ghana falls within the African meningitis belt where over 500 million people are at 
risk of epidemic meningitis. The district suffered an outbreak of Neisseria meningitides, W (NMW) in 2012 and a 
mixed outbreak of Streptococcus pneumonia and NMW in early 2016. We investigated the outbreak to identify the 
source, causative agents, and magnitude and assess health facility preparedness and propose control measures. 
Design and Setting: We conducted a descriptive study in all sub-districts of Jirapa, between 28th February to10th 
April 2016. We reviewed records at health facilities, assessed health facility preparedness, searched for cases, traced 
contacts of case to administer chemoprophylaxis and collect CSF for laboratory analysis. Data were entered in 
Microsoft excel cleaned, and exported to stata-13 for analysis by person place and time. 
Results: A total 233 meningitis cases were reported with mean age of 22.4years and standard deviation 21.6. Males 
were (57%), females (43%) and 60.8% were less than 19 years. Attack rate of meningitis was 214/100,000 with case 
fatality rate (CFR) of 12.4% (29/233). Causative agents were NMW (69.5%) and streptococcus pneumonia (27.1%), 
mainly serotype STN1 and H. influenza (3.4%). The index case had travel history to dollar power, close to Tain 
District which is the epicentre for the 2016 meningitis outbreak in Ghana. 
Conclusion: The Jirapa district experienced a mixed outbreak of streptococcal and meningococcal meningitis in 
early 2016, facilitated by migration. Active surveillance and mass vaccination with multivalent vaccines is required 
to protect the population. 
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INTRODUCTION 
The upper west region of Ghana falls within the African 
meningitis belt where over 500 million people are at 
risk of meningitis thus making the region prone to 
outbreaks of the disease.1,2 Epidemic meningitis 
continues to be a major public health problem in the 
extended African meningitis belt which comprises 26 
countries stretching from Ethiopia in east Africa to 
Senegal in the west.3 It has been observed that climate 
changes are affecting the areas that fall under this belt 
with meningitis outbreaks been reported in areas that 
were not part of this belt. 
Ghana recorded a major outbreak in 1997 in which 
18,703 cases and 1356 deaths were reported in the three 
northern regions.4 
 
In 2010 the Jirapa District and other parts of the Region 
experienced an outbreak of meningitis caused by N 
meningitides Y/W135 (NMW) Species. The disease is 
an inflammation of the brain and spinal cord coverings 
(Meninges) caused by microorganisms (Bacteria, 
parasites, viruses and fungi). It can also be caused by 
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Meningitis is characterized by symptoms ranging from 
fever, headache, neck stiffness, photophobia, muscle 
pains to vomiting and diarrhoea. Long term effects 
(sequelae) of meningitis include loss of hearing, brain 
damage, learning disability and seizures among others.5 
 Bacterial meningitis is caused mainly by Neisseria and 
Streptococcus species. However other bacteria can also 
cause the disease and causative agents vary with age 
and immune status. Haemophilus influenzae type b, 
Group B streptococci and E. coli are among agents of 
meningitis especially among children. Echoviruses, 
coxsackie viruses and fungi such as Cryptococcus are 
also known to cause meningitis.6  
 
Out of twelve (12) serotypes of N. meningitidis known 
to cause meningitis, six of them are associated with 
epidemics. These are serotypes, A, B, C, X, Y and 
W135/MNW.3 Transmission of the disease is mainly by 
direct person to person contact, through inhaling air 
droplets with infectious agents from infected persons 
via sneezing, coughing, talking and kissing.3 About 5-
20% of some populations are carriers of N. meningitis 
who serve as sources of infection.1,6,7  
 
About 10% of all bacterial meningitis results in death, 
however case fatality rates (CFR) for meningitis 
resulting from Streptococcus pneumoniae infections 
could be as high as 44%.8 About 10% patients infected 
with streptococcus pneumonia who receive effective 
antibiotics and intensive care still die.3   Factors that can 
increase a person’s risk of bacterial meningitis include: 
age, community setting, other medical conditions, 
working with meningitis causative agents and travel to 
meningitis endemic/epidemic areas. 
 
Prevention and control: key strategies for control are 
vaccination, public education and early diagnosis and 
treatment as well as continuous surveillance. Three 
major types of vaccines targeting various causative 
agents of bacterial meningitis are available for 
prevention. They include meningococcal A conjugate 
vaccine, C conjugate vaccines, tetravalent A, C, Y and 
W135 conjugate vaccines.  
 
Meningococcal polysaccharide vaccines   have all also 
been shown to be effective and immunogenic among 
adults and children above 2years.9  Polysaccharide 
vaccines can however not be developed for group 
streptococci due to antigenic mimicry with 
polysaccharides in humans neurologic tissues.1 As a 
result of this antigenic mimicry, scientist have resorted 
to the use of outer membrane protein (OMP) vaccines 
for prevention of Group B streptococcal meningitis. A 
new meningococcal conjugate vaccine, Men A which 
was introduced in 2010 with mass vaccinations among 
of people aged 1- 29 years in many African countries 
accounts for the drastic reduction in cases of 
Meningitidis A within the African meningitis belt.3,10 
This vaccine which is reported to have several 
advantages including being effective among children 
under two years, less expensive and able to reduce 
meningococcal carriage in vaccinated populations.3  
 
Penicillin, Ceftriaxone Ciprofloxacin, Rifampicin, 
Gentamicin are antibiotic that are commonly used for 
treatment and prophylaxis. Other preventive measure 
includes respiratory isolation of cases for 24 hour 
following commencement of treatment and tracing of 
contacts.6,11  
 
The Jirapa District as part of integrated disease 
surveillance trained key staff, in the district on 
meningitis surveillance and case management prior to 
the beginning of the meningitis season. This led to high 
index of suspicion and all persons with suspected 
meningitis were screened. On the 28th of December 
2015, a 22-year-old male from Jeffere, Kandieyiri a 
farming community, reported to the St Joseph’s hospital 
in Jirapa with symptoms of meningitis. Medical staff 
suspected meningitis and performed lumber puncture to 
collect CSF for Laboratory testing, the results were 
positive.  
 
Surveillance officers in the Jirapa District reported the 
first laboratory confirmed case of meningitis 
(Streptococcus pneumonia) for 2016 on 28th December. 
The District Health Management Team (DHMT) 
continued to monitor the situation in the District using 
the 2015 WHO revised standard operating procedure for 
epidemic meningitis.11 The District reached an alert 
thresh hold when it reported 9 suspected cases and 
confirmed three (3) of them in the second 
epidemiological reporting week of 2016. This threshold 
was reached based on the current projected population 
of the district (98,700)12 and the 2015 WHO standard 
operating procedures for meningitis surveillance.13 In 
the seventh week of 2016 the Jirapa District reached the 
epidemic threshold when it reported 30 suspected 
meningitis cases and confirmed 10 of them with 
laboratory test. As of 16th February 2016, 96 suspected 
cases of meningitis were reported and 26 were 
confirmed. Two main agents N. meningitides W135 and 
Streptococcus pneumoniae were isolated. 
 
A team of public health officials from the Ghana Field 
Epidemiology and Laboratory Training program 
(GFELTP) and a Joint team of Regional and District 
Public Health Officials investigated the outbreak to: 
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geographical spread, assess health facility preparedness, 




We conducted a descriptive epidemiological study, by 
reviewing records, defining cases and conducting cases 
search as well conducting interviews with health staff 
and patients. Health records at the St. Joseph’s Hospital 
in Jirapa and Jirapa District Health Directorate were 
reviewed to identify all reported cases of meningitis in 
the district between December 2015 and April 2016. We 
also assessed health facility preparedness using a check 
list. 
 
Study area  
The outbreak investigation was conducted in Jirapa 
District of the Upper West Region of Ghana between 
23rd February and 20th April 2016. The region is located 
in northwest Ghana (longitude 1o 25’’ W and 2o 45’’ 
and latitudes 9º 30’’ N and 11oN) and falls within the 
African meningitis belt. The District just like the rest of 
the region experiences a short raining season from June 
to October, followed by a long hot dry season from 
November to May. Maximum temperature is 22OC in 
the raining season and up to 40oC in the dry season. 
Humidity is typically between 70% to 90% in the 
raining season but can fall as low as 20% in the dry 
season14 which make the district prone to meningitis 
outbreaks. The projected population of the District is 
approximately 98,70012.  The district shares boundaries 
with Lawra, Lambusie-Karni, Nadowli- Kaleo, Sisala 
East and Dafiama-Busie- Issah Districts.  
 
Participants 
Cases definition and case search 
We formulated a surveillance case definition and used it 
to search for cases. We defined meningitis case as 
follows: 
Suspected case: Any person with sudden onset of fever 
(>38.5ºC rectal or38.0ºC axillary) and one of the 
following signs: neck stiffness, altered consciousness or 
other meningeal signs and   photophobia. In babies a 
bulging fontanel. 
Probable Case: A suspected case as define above with 
turbid CSF confirmed by a clinician and a positive gram 
stain result 
Confirmed case:  A suspected case confirmed by 
isolation of N. meningitides or Streptococcus 
pneumonia, H. Influenza or any other agent of 
meningitis.  
 
Based on the working definition, we searched new cases 
in health facilities and traced their contacts in 
communities. We continued line listing of cases and 
contact tracing. All close contacts of meningitis cases 
were given Ciprofloxacin as chemoprophylaxis.  
Health facilities were also assessed using a structured 
questionnaire and check list. We asked for presence of 
epidemic management team, displayed definitions, 
evidence of staff training, interventions for case 
management and availability of logistics and laboratory 
capacity. 
 
CSF collection and laboratory testing  
Cerebrospinal fluid (CSF) samples were collected at 
Jirapa Hospital into sterile cryo vials (tubes), (Greiner 
Bio-ine GmbH- Germany), tested by gram stain, culture, 
and serology (Pastorex, BIORAD- France and 
Wellcogen TM M. meningitidis ACY W135, REMEL 
Europe Ltd, UK.) at the Jirapa hospital Laboratory and 
later transported to the Public Health Reference 
Laboratory  in Tamale for PCR. 
 
Data Analysis 
Line list of cases was entered into Microsoft Excel 
2013, cleaned and exported to Stata software, Version 
13, (Texas, USA) for analysis. Data was analysed by 
person place and time to show age and sex groups, cases 
by sub-districts and time trends in the form of an 
epicure. We also calculated attack rates and case fatality 
rates.  Laboratory results were presented as frequencies 
and percentages.  
 
Ethical issues 
This was an outbreak situation and no formal clearance 
was obtained from an institutional review board, 
however permission was obtained from the Ghana 
Health Service regional and district health directorates. 
 
RESULTS 
General Characteristics of meningitis cases 
A total of 233 cases of suspected meningitis were 
reported in the Jirapa district of the upper west region of 
Ghana between December 28th 2015 and April 10th 
2016. Males were 133(57%) while females were 100 
(43 %). The mean age of cases was 22.4 years with a 
standard deviation of 21.6 years. Ages of cases ranged 
from 0.04 years (two weeks) to 87 years. Children 
below five years were most affected constituting 23.9 % 
of all cases, and those between 10 and 19 years (23.9%) 
of the total cases. Up to 60.8% of all the cases were less 
than 20 years (Figure 1). Out 233 cases 29 people died 
from meningitis representing a cases fatality rate of 
12.4%. The attack rate of meningitis in the District is 
214/100,000. 
 
Causative Agent and Laboratory Findings 
Out of 233 CSF samples collected, gram staining results 
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were gram positive cocci presumptively identified as 
Streptococcus pneumonia, 50 (21.6) were gram negative 
cocci and 162 (69.8%) did not show any organism. 
Overall, 70 out 232 (30.1%) of CSF samples tested by 
gram technique were positive. 
 
 Figure 1 Age and Sex Distribution of Meningitis cases, 
Jirapa District Upper West Region, Ghana, Jan-April 
2016 
 
Two key Pathogens were isolated from CSF samples 
collected from suspected meningitis cases; 
Streptococcus pneumoniae and Neisseria meningitides. 
There was a case of N. meningitidis A.  One person had 
a mixed infection with N. Meningitides W and 
Streptococcus pneumonia and died. All CSF samples 
were tested by gram stain, culture, serology (Pastorex 
BIORAD- France) in Jirapa hospital Laboratory and 
later transported to the special meningitis Laboratory in 
Tamale for PCR. Lumber puncture rate was 100% and 
73/233 (31.3%) CSF tested positive for meningitis. 
 
A total of 150 CSF sample from suspected meningitis 
cases collected from four Districts in the region 
including 102 (68%) from Jirapa District were 
transported to the Public health Reference laboratory in 
Tamale for PCR testing. Fifty-nine (39.3%) were 
confirmed and serotyped as follows:Out of the 59 PCR 
isolates 18 (31%) were Streptococcus pneumoniae and 
41(69%) were Neisseria meningitides W 135.  
 
Source of Outbreak  
 The index case was identified as a 22-year-old male 
from Jeffere, Kandieyiri who reported to the St. 
Joseph’s Hospital Jirapa hospital 28th December 2015. 
Cerebrospinal fluid was collected from the patient and 
sent to the laboratory for testing the same day. Gram 
positive diplococci was isolated and finally identified as 
Streptococcus pneumoniae. He had a travel history and 
was reported to have returned from a popular surface 
mining site called “Dollar Power” in the south-western 
part of Northern region which shares boundary with 
Tain district in the Brong Ahafo region which is the 
epicentre for the 2016 meningitis outbreak in Ghana.  
 
Magnitude and geographical spread of Cases 
A total of 233 cases were reported in the district within 
the period, with 212/233(90.9%) and of them resident in 
the District, while 21 (9.1%) were from other districts. 
Out 233 cases 29 people died from meningitis 
representing a cases fatality rate of 12.4%. The attack 
rate of meningitis in the District is 214/100,000. 
Pathogen specific attack rates were 51.4/100,000 
population for N. meningitides and 21.6/100,000 
populations for Streptococcus pneumonia.  Cases were 
reported from all sub-districts, however Jirapa Urban-
Tizza sub district contributed 130 (55.7%) of total 
reported cases. Out of fifty cases with confirmed 
Neisseria Meningitides ten died (10/50) representing a 
case fatality rate of 20%. Streptococcus Pneumonia was 
isolated from 20 patients and six of them died giving a 
CFR of 30%. Cases were reported from all sub-districts 
within the region and also from other Districts in the 




Figure 2 Distribution of meningitis cases by Sub- 
districts in Jirapa District, 28th December 2015 -10th 
April 2016 
 
Distribution of cases by time 
The Jirapa District started to report cases of meningitis 
from 28th December 2015, and went a pre-epidemic and 
epidemic phases within a space of two months or 8 
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The index case, a 22-year-old male from Jeferi with 
travel history from a popular surface mining site called 
“dollar power” was reported on the 28th of December 
2015 in the first epidemiological week of 2016.   
 
Other cases were detected within the vicinity close to 
the index case in the subsequent weeks. Based on the 
2015 WHO revised S.O.P for epidemic meningitis 
management11, the district reached alert threshold alert 
threshold in the second epidemiological week of 2016 
with 9 reported cases and confirmed three of them.  The 
District reached it epidemic threshold in week 7 when 
30 cases were reported and 10 of them confirmed. There 
has been a marginal drop in the number of cases from 
30 in week 7 to 29 in week 8. The epicurve (Figure 3) 
suggest a propagated outbreak that reached its Peak in 
the 7th week. The cases started to decline by week 9 and 
by the end of week 14, on one case of meningitis was 




Figure 3 Epicurve: Cases of Meningitis in Jirapa 
District 28th December- 10th April 2016 
 
 
Figure 4 Trend of Meningitis cases in Jirapa District 




Case management and Facility Assessment. 
 All cases have been managed with ceftriaxone and 
dexamethasone/mannitol as adjunctive treatment. 
Lumber was performed for all suspected meningitis case 
and Chemoprophylaxis in the form ciprofloxacin was 
given to all contacts of confirmed cases.  
 
All health workers working on patients were given 
ciprofloxacin as prophylaxis. Ceftriaxone and 
dexamethasone ere procured from through the national 
and regional medical stores 
 
Cases of meningitis were referred and reported from 
eight health facilities (6 health centers, one polyclinic 
and one district hospital). Only two (the polyclinic and 
district hospital) had capacity to perform lumber 
puncture and laboratory testing. There was an active 
epidemic management team in the district and evidence 
of training at all facilities. There was adequate supply of 
medicines (ceftriaxone) but lack laboratory reagents for 
serological testing. Health education was carried out in 
the community. The community members were 
educated on the preventive measures to reduce the 




Our result indicate that Jirapa District experienced an 
outbreak of meningitis within the first quarter of 2016. 
This outbreak is unique due to the mixed nature agents 
(Streptococcus pneumonia and Neisseria meningitis) 
that are associated with it. Though literature suggest that 
pneumococcal outbreak often pre-cede meningococcal 
meningitis out breaks, both outbreak seem to be 
occurring concurrently.  
 
Cases of Streptococcus Pneumonia started increasing 
from the year 2000 to 2003 in northern Ghana with 
serotypes ST 217, ST 303 and ST 6158.  The types of 
Streptococcus Pneumonia serotype isolated in this 
outbreak Streptococcus Pneumonia serotype 1 (SPN 
ST1). This same serotype was isolated from the 
outbreak in the south. There is a possibility that these 
two serotypes might be epidemiologically linked since 
the index case visited the epicentre of the outbreak in 
the Brong Ahafo region. 
 
A case of Neisseria meningitidis serogroup A NMA 
isolated from one case despite massive vaccination 
campaigns in the past suggest that some population may 
not be covered.15 From the results only one case each of 
H. influenzae and NMA were confirmed. A similar 
observation of few cases of the two agents was also 
observed by Opare and others who reviewed 
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could be attributed to the success of previous 
vaccination programmes.  The emergence of new strains 
of agents of meningitis in Ghana and the re-emergence 
of NMC in Niger indicate a greater potential of larger 
outbreaks in the meningitis belt.10 This calls for 
concerted efforts to tackle the disease through enhance 
surveillance and protection of the population with 
multivalent vaccine that target the agent isolated. 
Public education to encourage easy identification and 
early reporting to health facilities is best option for 
controlling the current outbreak.  Targeting a 
pneumococcal vaccine for the population could be 
difficult since different serotypes of Strep. Pneumonia 
are isolated in this outbreak. The possible source of 
cases of N meningitis W135 in this current outbreak 
could be due to immigration of non-immune subjects 
who have moved in from other districts. 
 
This is because in 2012, a massive immunization 
exercise was carried out in the Jirapa district for all 
those below and routine immunization continued in the 
district. Hence the resurgence of this could be explained 
by immigration of non-immune subjects into the district. 
A single case of meningitides A isolated from one 
patient could also be due this patient missing 
vaccination. Until 2010 most epidemics have been due 
to Neisseria meningitidis serogroup A (NmA), with 
others due to serogroups W, X and C. Since 2010, 
countries in the extended meningitis belt have started to 
introduce a new serogroup A meningococcal conjugate 
vaccine (MenAfriVac®) through mass campaigns16. 
While NmA has declined since 2010, as evidenced by 
fewer confirmed cases, the proportion of cases due to 
NmW, NmX and Streptococcus pneumoniae has risen. 
The proportion of suspected cases with laboratory 
confirmation across the belt has been rising (from 2–3% 
in 2003 to 6–7% in 2013)13, but is still at a relatively 
low level. However up to thirty percent of case in this 
outbreak were confirmed by laboratory test and this 
suggest improvements in laboratory capacity.  
 
Cases seem to have been imported from other districts 
and most of them reported that they have travelled from 
the southern part of the country. Our index case in this 
outbreak particularly had a travel from to popular 
surface mining site called dollar power. The poorly 
ventilated surface mine pits could also be a source of 
spread. The Tian district which report the first outbreak 
of meningitis in Ghana and later became the epicentre is 
closer to dollar power and also host a significant 
proportion of these surface miners. 
 
The high numbers of children of school going age, 
involved in this outbreak suggest that school could be a 
potential source of infections and must be particularly 
targeted in educational campaigns. From the epicurve, 
the district is still within alert threshold and there is the 
need to keep active surveillance. 
 
A major key limitation, of this study is our inability to 
conduct an analytical study to identify setting specific 
risk factors associated with the spread of meningitis in 
the district. We propose a case control study to 
determine the possible role of traditional funeral and 
burial rites, migration to and from surface mining sites 




In conclusion, the Jirapa district suffered an outbreak of 
Meningitis in the first quarter of 2016, which was 
caused by streptococcus pneumonia and Neisseria 
meningitides. The spread of this outbreak is by direct 
person to person contact facilitated by migration and 
surface mining activities. We recommend to health 
authorities to maintain surveillance, continue to analyse 
data to monitor the situation engage in public education 
on the need to avoid overcrowding and   complete all 
childhood immunisation schedules. All close contacts of 
confirmed cases should be traced and given 
chemoprophylaxis. There is also a need for health 
facilities to prepare with adequate logistics and reagents 
ahead of the meningitis season in the future. In the long 
term multivalent vaccines targeting NMW and 
streptococcus pneumonia serotype one (SPN ST 1) 
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